Inizia
ReutersReuters

Xilio Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

RefinitivMeno di 1 minuto di lettura
XLO

  • Xilio Therapeutics Inc XLO is expected to show a rise in quarterly revenue when it reports results on August 6 (estimated) for the period ending June 30 2025

  • The Waltham Massachusetts-based company is expected to report a 214.0% increase in revenue to $7.4 million from $2.36 million a year ago, according to the estimate from one analyst, based on LSEG data.

  • ​LSEG's mean analyst estimate for Xilio Therapeutics Inc is for a loss of 10 cents per share.

  • The one available analyst rating on the shares is "buy".

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

AmericaAzioni USAReport finanziariReuters
refinitivrefinitiv
© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html
Accedi o crea un account gratuito per leggere queste notizie

Altre notizie da Reuters